Morgan Stanley Check Cap LTD Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.06 - $7.2 $2,263 - $271,620	37,725 Added 182.95%	58,345 $17,000
Q2 2022 Oct 27, 2022	BUY	$0.31 - $0.4 $5,431 - $7,008	17,520 Added 565.16%	20,620 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.31 - $0.4 $5,431 - $7,008	17,520 Added 565.16%	20,620 $6,000
Q1 2022 Oct 27, 2022	SELL	$0.37 - $0.69 $6,482 - $12,088	-17,520 Reduced 84.97%	3,100 $1,000
Q4 2021 Feb 14, 2022	BUY	$0.66 - $1.11 $1,386 - $2,331	2,100 Added 210.0%	3,100 $2,000
Q3 2021 Nov 15, 2021	BUY	$0.88 - $1.22 $880 - $1,220	1,000 New	1,000 $1,000

9.1K

Ticker CHEK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 116,412,000
Market Cap $72.2M
Description
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for d...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.